Jean-Jacques Jennings M.Sc.’s Post

View profile for Jean-Jacques Jennings M.Sc., graphic

Business Development Manager - Immunexpress / SeptiCyte RAPID - 1st FDA cleared host-response, Gene Expression, for Sepsis, that aids clinicians to make time sensitive decisions to reduce mortality!

🥸 The SeptiCyte RAPID result can help determine what to do with the sample for blood culture. Running the 60 min test with the blood draw could help reduce the number of unnecessary blood cultures and may provide relief and effective inventory management for best patient outcomes ❤️. #cultures #BDBactec #infectionprevention #sepsis #antibioticstewardship.

View organization page for Immunexpress Inc., graphic

1,862 followers

Healthcare providers, how are you addressing the shortage in BD BACTEC blood culture media bottles? The FDA recommends prioritizing the use of blood cultures for patients with clinical signs of a bloodstream infection. SeptiCyte® RAPID, a sepsis diagnostic test, has been approved by the FDA to differentiate #sepsis from non-infectious SIRS directly from blood within 60 minutes. SeptiCyte® RAPID can directly support preserving blood culture media for patients at high sepsis risk during this critical supply shortage. Learn more: https://bit.ly/4e6AC5N

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics